Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment

Overview of attention for article published in Arthritis Research & Therapy, April 2004

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 135 Dimensions

Readers on

mendeley: 43 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof

Grant US-8323656-B2

United States of America

METHODS AND COMPOSITIONS FOR USE IN TREATMENT OF PATIENTS WITH AUTOANTIBODY POSITIVE…

Application EP-1933873-A4

European Patent Office

METHODS AND COMPOSITIONS FOR USE IN TREATMENT OF PATIENTS WITH AUTOANTIBODY POSITIVE…

Application EP-1933873-A2

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.